Genotech Symposium 2025

Our 2025 Institute for Human Genetics Genotech Symposium was a huge success with captivating talks that focused on basic science and translational work across selected topics in gene therapy, AI, and genomic technologies.

With over 500 registrants, there were many fruitful interactions and collaborations with talks by industry leaders/faculty, panel discussions, and social events.

Special thanks to our sponsors Mission BioVector Builder, NabsysTakara BioIllumina, Element Biosciences, 10x Genomics, BD, N6 Tec, LexigenBio, Complete Genomics, PacBioGENEWIZ from Azenta Life Sciences, Scale Biosciences, and QIAGEN for helping make this event possible!

Thanks to Michael Snyder, Talmadge King, Jacob Kimmel, Dan Hart, Paul Donohoue, Chris Hsiung, KT Moortgat, Kyle Farh, Shishi Luo, Xiao Yang, Jeff Spence, Kathleen Barnes, Mike Schnall-Levin, Matthew Kellinger, Diego Calderon, and Nick Page for the outstanding talks!

We thank you all for your participation and look forward to seeing you next year.

 

Genotech Symposium 2025 Photos
g
g
g
g
g
g
g
g
g
g
g
g
g
g
g
g
g
g
g
g
g
g
g
g
g
g
g
g
g
g
g
g
g
g
g
g
g
g
g
g
g
g
g
g
g
g
g
g
g
g
g
g
g
g
g
g
g
g
g
g
g
g
g
g
g
g
g
g
g
g
g
g
g
g
g
g
g
g
g
g
g
g
g
g
g
g
g
g
g
g
g
g
g
g
g
g
g
g
g
g
g
g
g
g
g
g
g
g
g
g
g
g
g
g
g
g
g
g
g
g
g
g
g
g
g
g
g
g
g
g

 

Agenda:

TimeWhoTitleTalk Title
Introductions9:00-9:05Talmadge E. King Jr., MD

Dean, School of Medicine, UCSF

Vice Chancellor, Medical Affairs, UCSF Health

9:05-9:15Nadav Ahituv, PhDDirector, UCSF Institute for Human Genetics
Gene Therapy9:15-9:35Jacob Kimmel, PhDCo-founder & President, NewLimitRestoring youthful function with reprogramming therapies
9:35-9:55Dan Hart, PhDHead of Platform, Epicrispr BiotechnologiesEPIC GEMS: An Epigenetic Editing Platform for In vivo Therapeutic Applications
9:55-10:15Paul DonohoueDirector of Platform Discovery, Caribou BiosciencesA versatile CRISPR hybrid RNA-DNA editing technology for the generation of off-the-shelf cell therapies
10:15-10:35Chris Hsiung, MD, PhDAssistant Professor, Institute for Human Genetics and Dept. of Surgery, UCSFHigher-order combinatorial functional genomics
10:35-11:05Panel Discussion
Coffee Break11:05-11:35
Keynote Speaker11:35-12:20Michael Snyder, PhDStanford W. Ascherman Professor of Genetics, Stanford UniversityThe Genetic Basis of Complex Diseases Revealed Using AI methods
Lunch & Career panel12:20-1:35

KT Moortgat, PhD

 

Shishi Luo, PhD

 

Mike Schnall-Levin, PhD

 

Michael Snyder, PhD

Founder, Managing Partner, Dalena Capital
 

Director of Bioinformatics, Helix
 

Chief Technology Officer, Founding Scientist, 10X Genomics
 

Stanford W. Ascherman Professor of Genetics, Stanford University

The career panel will be a round table discussion. Nick Page, Neuroscience PhD, will lead the discussion with a few questions to get the ball rolling and from there we can take questions from trainees in the audience. Come learn more about exciting and impactful career paths in the biotech industry. To join, register here and take your lunch to room GH-N114 on the first floor of the Genentech building.
AI1:35-1:55Kyle Farh, MD, PhDVP & Distinguished Scientist, Illumina Artificial Intelligence LabPrimateAI-3D resolves variants of unknown significance (VUS) by leveraging large-scale evolutionary data
1:55-2:15Shishi Luo, PhDDirector of Bioinformatics, HelixPrecision Medicine: From Exome Data to Drug Response with a Little Help from LLMs
2:15-2:35Xiao Yang, PhDCo-founder & CEO, PromptBioPromptBio: A Multi-Agent AI Platform for Bioinformatics Data Analysis
2:35-2:55Jeff Spence, PhDAssistant Professor, Department of Epidemiology & Biostatistics, UCSFAccurate estimation of gene constraint by combining interpretable models and machine learning
2:55-3:25Panel Discussion
Coffee Break3:25-3:55
Genomic Technologies3:55-4:15Kathleen Barnes, PhDSVP Population & Precision Health, Oxford NanoporePopulation and Precision Health Powered by Oxford Nanopore Multiomics Solutions
4:15-4:35Mike Schnall-Levin, PhDChief Technology Officer, Founding Scientist, 10X GenomicsDriving the Next Level of Scale of Single Cell and Spatial
4:35-4:55Matthew Kellinger, PhDCo-founder & VP of Biochemistry, Element BiosciencesUnleashing the Multiomic Capabilities of AVITI24 to Empower Discovery
4:55-5:15Diego Calderon, PhDAssistant Professor, Department of Bioengineering and Therapeutic Sciences, UCSFThe continuum of gene regulation at single-cell resolution, from Drosophilia development to human complex traits
5:15-5:45Panel Discussion
Reception5:45